Is NPH associated with fewer adverse events than analog basal insulin for adults with T2D? | Zendy

Lyon | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Is NPH associated with fewer adverse events than analog basal insulin for adults with T2D?

Author(s) -

Lyon

Publication year - 2021

Publication title -

the journal of family practice

Language(s) - English

Resource type - Journals

eISSN - 1533-7294

DOI - 10.12788/jfp.0191

Subject(s) - hypoglycemia , observational study , insulin glargine , medicine , randomized controlled trial , emergency department , adverse effect , basal insulin , nph insulin , basal (medicine) , insulin , pediatrics , emergency medicine , intensive care medicine , type 2 diabetes , diabetes mellitus , endocrinology , psychiatry

NO. Insulin glargine may lead to less patient-reported, symptomatic, and nocturnal hypoglycemia, although overall, there may not be a difference in the risk for severe hypoglycemia orhypoglycemiarelated emergency department (ED) visits and hospitalizations (strength of recommendation [SOR]: B, systematic review of randomized controlled trials [RCTs], individual RCTs, and observational study).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research